Weekly vs. Every-3-Week Paclitaxel for Ovarian Cancer
- PMID: 27355550
- DOI: 10.1056/NEJMc1603849
Weekly vs. Every-3-Week Paclitaxel for Ovarian Cancer
Comment in
-
Weekly vs. Every-3-Week Paclitaxel for Ovarian Cancer.N Engl J Med. 2016 Jun 30;374(26):2603-4. doi: 10.1056/NEJMc1603849. N Engl J Med. 2016. PMID: 27355549 No abstract available.
Comment on
-
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.N Engl J Med. 2016 Feb 25;374(8):738-48. doi: 10.1056/NEJMoa1505067. N Engl J Med. 2016. PMID: 26933849 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical